Skip to content

MOTIV8 - Treatment Motivation in Forensic Youth Treatment

Motiv8: Examining Treatment Motivation Among Youth and Parents in Forensic Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06474156
Enrollment
16
Registered
2024-06-25
Start date
2024-03-05
Completion date
2025-10-31
Last updated
2024-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motivation

Keywords

Treatment Motivation, Multidimensional Family Therapy, Youth, Parents, Delinquency

Brief summary

This project entails to gain a deeper understanding of the development of treatment motivation over the course of intramural and outpatient forensic youth care. Research questions are 1) How does treatment motivation of youth and parents develop over the course of forensic systemic therapy, and following the transition from inpatient to outpatient therapy?; 2) Which client factors, interpersonal factors, and contextual characteristics moderate the development of treatment motivation?; 3) Which mechanisms play a role in the development of treatment motivation?; and 4) How does treatment motivation affect treatment retention and the achievement of primary therapy goals?

Detailed description

Multidimensional Family Therapy (MDFT) has been shown to motivate youth and parents in forensic care for treatment. The current study will investigate the development of treatment motivation of youth and parents over the course of MDFT, offered in a juvenile justice center. Furthermore, mechanisms and moderators will be examined, in addition to the impact of treatment motivation on treatment retention and goal achievement. Two studies with a Multiple Case Experimental Design (MCED), one with an ABC design (A = baseline, B = residential MDFT, and C = outpatient MDFT) and one with an AB design, will be conducted. Juveniles who enter residential MDFT, during a short detention period (study 1; 10 cases) or during a longer detention period (study 2; 6 cases) will be recruited, as will their parents.

Interventions

Multidimensional family therapy is a manualized,evidence-based, intensive intervention program with assessment and treatment modules focusing on four areas: (a) the individual adolescents' issues regarding substance use disorder, delinquency, and comorbid psychopathology, (b) the parents' child-rearing skills and personal functioning, (c) communication and relationship between adolescent and parent(s), and (d) interactions between family members and key social systems (Liddle, 2002).

Sponsors

Kwaliteit Forensische Zorg Jeugd
CollaboratorUNKNOWN
University of Amsterdam
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
12 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

\- entering residential MDFT

Exclusion criteria

\- (only for short term residents) residing more than an hours' drive from the juvenile justice center after detention

Design outcomes

Primary

MeasureTime frameDescription
Treatment motivation youth perspective (validated questionnaires)at least 5 times during phase A (2-6 weeks); every other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Treatment Motivation Questionnaire for Adolescents (van der Helm et al., 2013; van der Helm et al., 2018; 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree), with a higher score indicating more motivation for treatment; Cooperation Scale (Tolan et al., 2002; 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree. A higher total score indicates more motivation for treatment).
Treatment motivation caregiver perspective (validated questionnaires)at least 5 times during phase A (2-6 weeks); every other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Parent Motivation Inventory (Nock & Photos, 2006); Cooperation Scale (Tolan et al., 2002). Participants respond on a 5-point Likert scale on both questionnaires ranging from 1 (completely disagree) to 5 (completely agree). Higher total scores indicate more motivation for treatment.
Treatment motivation therapist perspective (validated questionnaires)every other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Cooperation Scale (Tolan et al., 2002; 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates more motivation for treatment).
Treatment motivation (qualitative data)Youth/Caregivers: at the end of each phase (A (after 2-6 weeks), B (after 1-9 months) and C (after 1-3 months))Youth/Caregivers: semi-structured interview

Secondary

MeasureTime frameDescription
Therapeutic alliance youth perspectiveevery other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Session Rating Scale (SRS; Duncan et al., 2003). The SRS is scored by adding the total of the client's marks on the four 10-cm lines, with a higher total score indicating a stronger alliance.
Therapeutic alliance caregiver perspectiveevery other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Session Rating Scale (Duncan et al., 2003). The SRS is scored by adding the total of the client's marks on the four 10-cm lines, with a higher total score indicating a stronger alliance.
Sense of competence youth perspectiveat least 5 times during phase A (2-6 weeks); every other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Basic Psychological Need Satisfaction and Frustration Scale (Chen et al., 2015), subscales Competence Satisfaction and Competence Frustration. Participants respond on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). A higher total score indicates a higher sense of competence.
Sense of competence caregiver perspectiveat least 5 times during phase A (2-6 weeks); every other week during phase B (1-9 months; at least 5 assessments), at least 5 times during phase C (1-3 months).Basic Psychological Need Satisfaction and Frustration Scale (Chen et al., 2015), subscales Competence Satisfaction and Competence Frustration. Participants respond on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). A higher total score indicates a higher sense of competence.
Aggression and rule-breaking behavior youth perspectiveThe complete subscale is administered in phase A (2-6 weeks), every other week during phase B (1-9 months) and C (1-3 months) the (3-5) items reflecting the most severe problems are selected.Youth Self Report (YSR; Achenbach, 1991), subscale aggression and rule-breaking behavior. Youth complete the YSR by rating their behavior on a three-point scale for the 30 items in this subscale. Specifically, the child rates the behavioral symptoms as '0' if not present, a '1' if the child sometimes exhibits the symptom and '2' if the child frequently demonstrates the symptom. A higher total score indicates more aggression and rule breaking behavior.
Aggression and rule-breaking behavior caregiver perspectiveThe complete subscale is administered in phase A (2-6 weeks), every other week during phase B (1-9 months) and C (1-3 months) the (3-5) items reflecting the most severe problems are selected.Child Behavior Checklist (CBCL; Achenbach, 1991), subscale aggression and rule-breaking behavior. Parents complete the CBCL by rating their children on a three-point scale for the 30 items in this subscale. Specifically, a parent rates the behavior as a '0' if it is not present, a '1' if the child sometimes exhibits the symptom, and a '2' if the child frequently demonstrates the symptom. A higher total score indicates more aggression and rule breaking behavior.

Countries

Netherlands

Contacts

Primary ContactHanneke E Creemers
h.e.creemers@uva.nl+31 (0)6 55 40 28 94
Backup ContactJet Westerveld
j.westerveld@uva.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026